Bridging the gap between epigenetics and cisplatin resistance: Implications for oral cancer management
• Cisplatin resistance is a major challenge in oral cancer treatment, leading to poor outcomes. • Epigenetic factors such as DNA methylation, histone changes, and non-coding RNAs play key roles in resistance. • DNA methylation silences MGMT, impairing DNA repair and promoting resistance. • Combination therapy with epigenetic drugs and cisplatin may overcome resistance and improve outcomes.
Authors
- Monisha Prasad (ORCID: https://orcid.org/0000-0003-2185-8121)
- Ameerunnisha begum
Institutions
- Saveetha University (IN)
Publication Details
- Journal
- Oral Oncology Reports
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.oor.2024.100649
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00